Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients

Crit Care Med. 2003 Aug;31(8):2090-5. doi: 10.1097/01.CCM.0000079606.16776.C5.

Abstract

Objective: To determine whether selective digestive decontamination (SDD) had some negative impact on the bacterial resistance observed in strains isolated from samples from patients receiving nonabsorbable antibiotics and cefazolin.

Design: Case-control study.

Setting: Intensive care unit of a university tertiary-care hospital.

Patients: Over a 6-yr period, 360 multiple trauma patients (case patients) submitted to SDD were compared with 360 patients not receiving SDD (controls).

Interventions: SDD consisted of polymyxin E, gentamicin, and amphotericin B and was applied on the buccal mucosa and provided in the nares and the stomach. For the first 3 days, systemic cefazolin (1 g three times a day) was provided. Resistance analysis was performed in case patients and controls on samples collected at predetermined intervals.

Measurements and main results: SDD was used in a small subset of patients admitted to the intensive care unit (360 of 5987 over the 6-yr study period). A relative overgrowth of gram-positive cocci was observed. Methicillin resistance of Staphylococcus epidermidis was increased (SDD 76%, controls 63%, p <.05) but not that of Staphylococcus aureus (SDD 20%, controls 18%). Resistance of Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter to beta-lactamines and aminoglycosides was the same in SDD patients and controls.

Conclusions: When used in a small subset of patients who have been shown to derive benefit from it (patients who have experienced multiple trauma), SDD has a moderate impact on microbial ecology. However, surveillance cultures are indispensable because the absence of resistance to SDD antibiotics determines the long-term safety of the SDD prophylaxis.

MeSH terms

  • APACHE
  • Administration, Cutaneous
  • Administration, Oral
  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Antibiotic Prophylaxis*
  • Case-Control Studies
  • Colistin / administration & dosage
  • Colistin / pharmacology
  • Cross Infection / complications
  • Cross Infection / microbiology*
  • Cross Infection / prevention & control
  • Drug Resistance, Bacterial*
  • Female
  • France
  • Gentamicins / administration & dosage
  • Gentamicins / pharmacology
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / physiology
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / physiology
  • Hospitals, University
  • Humans
  • Intensive Care Units
  • Male
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Middle Aged
  • Multiple Trauma / complications*
  • Multiple Trauma / microbiology
  • Multiple Trauma / pathology
  • Retrospective Studies
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / physiology

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Amphotericin B
  • Colistin